TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
This Quarter Return
+32.47%
1 Year Return
-56.28%
3 Year Return
-45.76%
5 Year Return
+44.93%
10 Year Return
–
AUM
$348M
AUM Growth
+$348M
(+34%)
Cap. Flow
+$20.1M
Cap. Flow
% of AUM
5.77%
Top 10 Holdings %
Top 10 Hldgs %
58.54%
Holding
41
New
8
Increased
9
Reduced
11
Closed
9
Top Buys
| 1 |
ICU Medical
ICUI
|
$12.3M |
| 2 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$11M |
| 3 |
Lantheus
LNTH
|
$10.7M |
| 4 |
UnitedHealth
UNH
|
$10.3M |
| 5 |
Labcorp
LH
|
$9.14M |
Top Sells
| 1 |
AtriCure
ATRC
|
$16.9M |
| 2 |
MDRX
Veradigm Inc. Common Stock
MDRX
|
$8.19M |
| 3 |
Viatris
VTRS
|
$8.04M |
| 4 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
$6.99M |
| 5 |
Merck
MRK
|
$6.93M |
Sector Composition
| 1 | Healthcare | 92.85% |
| 2 | Technology | 5.52% |
| 3 | Materials | 1.64% |
| 4 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Pacira BioSciences
PCRX
$1.2B
| $36.7M | 10.23% | 700,000 +150,000 | +27% | +$7.87M |
|
2
Quest Diagnostics
DGX
$20.3B
| $31.3M | 8.73% | 275,000 -42,000 | -13% | -$4.79M |
|
3
Perrigo
PRGO
$3.27B
| $26.3M | 7.31% | 475,000 +75,000 | +19% | +$4.15M |
|
4
United Therapeutics
UTHR
$13.8B
| $21.2M | 5.9% | 175,000 +14,000 | +9% | +$1.69M |
|
5
Hologic
HOLX
$14.9B
| $18.5M | 5.16% | 325,000 -55,000 | -14% | -$3.14M |
|
|
NUAN
6
DELISTED
Nuance Communications, Inc.
NUAN
| $14.6M | 4.05% | 575,000 -50,000 | -8% | -$1.27M |
|
|
7
ICU Medical
ICUI
$3.15B
| $14.4M | 4% | 78,000 +67,000 | +609% | +$12.3M |
|
8
Medtronic
MDT
$119B
| $13.8M | 3.83% | 150,000 -75,000 | -33% | -$6.88M |
|
|
9
Lantheus
LNTH
$3.73B
| $13.6M | 3.78% | 950,000 +750,000 | +375% | +$10.7M |
|
10
Bio-Rad Laboratories Class A
BIO
$8.06B
| $13.5M | 3.77% | 30,000 -10,000 | -25% | -$4.52M |
|
11
Rigel Pharmaceuticals
RIGL
$697M
| $12.5M | 3.49% | 6,850,000 +1,300,000 | +23% | +$2.38M |
|
|
OPTN
12
DELISTED
OptiNose
OPTN
| $11.3M | 3.16% | 1,525,000 -25,000 | -2% | -$186K |
|
13
Phreesia
PHR
$1.88B
| $11.3M | 3.15% | 400,000 +150,000 | +60% | +$4.24M |
|
14
RadNet
RDNT
$5.52B
| $11.1M | 3.09% | 700,000 +475,000 | +211% | +$7.54M |
|
|
GWPH
15
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $11M | 3.08% | +90,000 | New | +$11M |
|
|
MDRX
16
DELISTED
Veradigm Inc. Common Stock
MDRX
| $10.8M | 3.02% | 1,600,000 -1,210,000 | -43% | -$8.19M |
|
|
17
UnitedHealth
UNH
$281B
| $10.3M | 2.87% | +35,000 | New | +$10.3M |
|
|
18
AtriCure
ATRC
$1.84B
| $10.1M | 2.82% | 225,000 -375,000 | -63% | -$16.9M |
|
|
19
Labcorp
LH
$23.1B
| $9.14M | 2.54% | +55,000 | New | +$9.14M |
|
20
Abbott
ABT
$231B
| $6.86M | 1.91% | +75,000 | New | +$6.86M |
|
|
21
Viatris
VTRS
$12.3B
| $6.43M | 1.79% | 400,000 -500,000 | -56% | -$8.04M |
|
|
STRM
22
DELISTED
Streamline Health Solutions
STRM
| $5.73M | 1.59% | 4,305,882 | – | – |
|
|
AMRS
23
DELISTED
Amyris Inc.
AMRS
| $5.69M | 1.59% | +1,333,333 | New | +$5.69M |
|
|
ISEE
24
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $5.1M | 1.42% | 1,000,000 -250,000 | -20% | -$1.28M |
|
25
Plexus
PLXS
$3.7B
| $4.66M | 1.3% | +66,000 | New | +$4.66M |
|